D.Western Therapeutics Institute, Inc. [4576.T]
TOKYO, May 01 (Pulse News Wire) – D.Western Therapeutics Institute, Inc. (4576.T) reported today that no warrants from its 13th series of warrant issues (with adjustment clauses) were exercised in April 2026.
As of the end of March, there were 9,098 outstanding warrants, which decreased to 9,098 by the end of April. The total number of warrants remains unchanged at 0.00%. No shares were delivered during the month, and the exercise ratio remained at zero.
The company noted that the exercise limit based on the Tokyo Stock Exchange's listing regulations and the Securities Association’s rules was adhered to, with the exercise rate calculated as 0.00%. Detailed information on the issuance of the 13th series of warrants can be found in the notice published on July 15, 2025. The 13th series of warrants were initially issued on July 31, 2025.
The company maintains strict adherence to regulatory requirements concerning the exercise of these warrants.
🟢 Confidence: High AI-translated content.